Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 278-284

  Halwani, Majed ^a   Blomme, Shanna ^a   Suntres, Zacharias E ^a,b   Alipour, Misagh ^a   Azghani, Ali O ^c   Kumar, Aseem ^a,b   Omri, Abdelwahab ^a  

^a LAURENTIAN UNIVERSITY   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

^c UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

Bacterial adhesion; Burkholderia cenocepacia; Liposomal (bismuth ethanedithiol); MBCs; MICs; Pseudomonas aeruginosa; Staphylococcus aureus; Toxicity

Indexed keywords

BISMUTH DERIVATIVE; BISMUTH ETHANEDITHIOL; LACTATE DEHYDROGENASE; LIPOSOME; PHOSPHATE BUFFERED SALINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; BURKHOLDERIA CENOCEPACIA; CANCER CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; ENZYME ASSAY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MINIMUM INHIBITORY CONCENTRATION; PLASMA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STORAGE TEMPERATURE;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BURKHOLDERIA CEPACIA; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CULTURE MEDIA; DRUG CARRIERS; DRUG STABILITY; HUMANS; LIPOSOMES; LUNG; MERCAPTOETHANOL; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 44449092936     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.03.008     Document Type: Article

References (41)

1. Alipour M., et al. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int. J. Pharm. 355 (2008) 293-298
2. Alkawash M.A., et al. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. Apmis 114 (2006) 131-138
3. Angioli R., et al. Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies. Int. J. Gynecol. Cancer 17 (2007) 88-93
4. Azghani A.O., et al. Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture. Microb. Pathogen. 33 (2002) 109-114
5. Bekersky I., et al. Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats. Pharm. Res. 17 (2000) 1494-1502
6. Berridge M.V., and Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303 (1993) 474-482
7. Burkhardt O., et al. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?. J. Antimicrob. Chemother. 58 (2006) 822-829
8. Cordeiro C., et al. Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrob. Agents Chemother. 44 (2000) 533-539
9. Cunha M.V., et al. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol. 42 (2004) 3052-3058
10. Desjardins A., et al. Differential behaviour of fluid liposomes toward mammalian epithelial cells and bacteria: restriction of fusion to bacteria. J. Drug Target 10 (2002) 47-54
11. Dill K., and McGown E.L. The biochemistry of arsenic, bismuth and antimony. In: Patai S. (Ed). The Chemistry of Organic Arsenic, Antimony and Bismuth Compounds (1994), John Wiley & Sons, New York, NY 695-713
12. Domenico P., et al. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrob. Agents Chemother. 41 (1997) 1697-1703
13. Domenico P., et al. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob. Agents Chemother. 45 (2001) 1417-1421
14. Fetterly G.J., and Straubinger R.M. Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS Pharm. Sci. 5 (2003) E32
15. Garcia-Medina R., et al. Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect. Immun. 73 (2005) 8298-8305
16. Govan J.R., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60 (1996) 539-574
17. Halwani M., et al. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J. Antimicrob. Chemother. 60 (2007) 760-769
18. Henry D.A., et al. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 39 (2001) 1073-1078
19. Huang C.T., and Stewart P.S. Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment. J. Antimicrob. Chemother. 44 (1999) 601-605
20. Hunt C.A. Liposomes disposition in vivo. V. Liposome stability in plasma and implications for drug carrier function. Biochim. Biophys. Acta 719 (1982) 450-463
21. Marier J.F., et al. Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats. J. Antimicrob. Chemother. 52 (2003) 247-252
22. Miller M.B., and Gilligan P.H. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J. Clin. Microbiol. 41 (2003) 4009-4015
23. Moore R.A., and Hancock R.E. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30 (1986) 923-926
24. Moskowitz S.M., et al. Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr. Radiol. 35 (2005) 739-757
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
26. Mugabe C., et al. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J. Antimicrob. Chemother. 55 (2005) 269-271
27. Mugabe C., et al. Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int. J. Pharm. 307 (2006) 244-250
28. Mugabe C., et al. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50 (2006) 2016-2022
29. Murata T. Effects of bismuth contamination on the growth and activity of soil microorganisms using thiols as model compounds. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 41 (2006) 161-172
30. Poole K. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr. Pharm. Biotechnol. 3 (2002) 77-98
31. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10 (2004) 12-26
32. Rukholm G., et al. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int. J. Antimicrob. Agents 27 (2006) 247-252
33. Saiman L., et al. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect. Immun. 58 (1990) 2578-2584
34. Schiffelers R., et al. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J. Antimicrob. Chemother. 48 (2001) 333-344
35. Senior J., and Gregoriadis G. Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes. Biochim. Biophys. Acta 1003 (1989) 58-62
36. Veloira W.G., et al. In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex. J. Antimicrob. Chemother. 52 (2003) 915-919
37. Vinion-Dubiel A.D., and Goldberg J.B. Lipopolysaccharide of Burkholderia cepacia complex. J. Endotoxin Res. 9 (2003) 201-213
38. Vyas S.P., et al. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int. J. Pharm. 296 (2005) 12-25
39. Walters M.C., et al. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47 (2003) 317-323
40. Wei S., et al. Cystic fibrosis testing among Arab-Americans. Genet. Med. 8 (2006) 255-258
41. Wu C.L., et al. Subinhibitory bismuth-thiols reduce virulence of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 26 (2002) 731-738